Legal & General Group
DAWN

Legal & General Group’s Day One Biopharmaceuticals DAWN Stock Holding History

Legal & General Group’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11M Sell
51,763
-11,905
-19% -$168K ﹤0.01% 2109
2025
Q4 		$593K Buy
63,668
+6,804
+12% +$56.8K ﹤0.01% 2369
2025
Q3 		$401K Hold
56,864
– – ﹤0.01% 2505
2025
Q2 		$370K Sell
56,864
-3,701
-6% -$25.5K ﹤0.01% 2523
2025
Q1 		$480K Buy
60,565
+2,942
+5% +$31.7K ﹤0.01% 2408
2024
Q4 		$730K Buy
57,623
+1,359
+2% +$18.9K ﹤0.01% 2333
2024
Q3 		$784K Buy
56,264
+1,087
+2% +$15.5K ﹤0.01% 2315
2024
Q2 		$760K Buy
55,177
+1,753
+3% +$25.6K ﹤0.01% 2286
2024
Q1 		$883K Sell
53,424
-67
-0.1% -$1K ﹤0.01% 2233
2023
Q4 		$781K Sell
53,491
-239
-0.4% -$2.9K ﹤0.01% 2284
2023
Q3 		$659K Buy
53,730
+4,630
+9% +$60.4K ﹤0.01% 2327
2023
Q2 		$586K Buy
49,100
+46,515
+1,799% +$608K ﹤0.01% 2409
2023
Q1 		$34.6K Hold
2,585
– – ﹤0.01% 2934
2022
Q4 		$55.6K Hold
2,585
– – ﹤0.01% 2938
2022
Q3 		$52K Buy
2,585
+561
+28% +$11.9K ﹤0.01% 2963
2022
Q2 		$36K Sell
2,024
-159
-7% -$1.64K ﹤0.01% 3069
2022
Q1 		$22K Buy
2,183
+1,156
+113% +$15.3K ﹤0.01% 3210
2021
Q4 		$17K Hold
1,027
– – ﹤0.01% 3322
2021
Q3 		$24K Buy
+1,027
New +$24.6K ﹤0.01% 3209

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Legal & General Group's DAWN Position: Q1 2026 in Review

Legal & General Group reduced its Day One Biopharmaceuticals (DAWN) stake by 19% in Q1 2026, selling an estimated $168K and leaving 51,763 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2109.

Legal & General Group first reported a position in DAWN in Q3 2021 and has held it in 19 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Legal & General Group held 51,763 shares of Day One Biopharmaceuticals worth $1.11M as of Q1 2026.
  • Legal & General Group sold 11,905 Day One Biopharmaceuticals shares in Q1 2026, an estimated $168K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2109 holding.
  • Legal & General Group first reported a position in Day One Biopharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.